Photoacoustic imaging contrast agent for cancer diagnosis as well as preparation method and application thereof
A cancer diagnosis and photoacoustic imaging technology, applied in the fields of nanotechnology and cancer diagnosis, to achieve the effect of reducing two-dimensional size, low density, and excellent real-time performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] A method for preparing a photoacoustic imaging contrast agent for cancer diagnosis, comprising the steps of:
[0040] S1, in 1g Ti 3 AlC 2 Add 1 g of LiF solid, slowly add 10 mL of concentrated hydrochloric acid, stir at room temperature for 72 h, centrifuge at 8000 rpm to discard the supernatant, wash the product by centrifugation with deionized water, add 1 mL of DMSO as an intercalation agent, and sonicate for 1 hour to increase Ti 3 C 2 T x Layer spacing, centrifuged at 8000rpn, discarded supernatant, the product obtained was washed by centrifugation with deionized water, the centrifugal speed was 8000rpn, and the number of washings was 3 times. 3 C 2 T x powder;
[0041] S2, get 1g of Ti prepared in step S1 3 C 2 T x Ultrasonically disperse the powder in 50mL of ultrapure water, add 2g of dopamine hydrochloride, and stir at room temperature for 1h in the dark, then add 25mL of 0.1mol / L Tris buffer solution, add dilute hydrochloric acid dropwise to adjust ...
Embodiment 2
[0050] This example provides a method for preparing a photoacoustic imaging contrast agent for cancer diagnosis. Compared with Example 1, the difference is that the polydopamine modification in step S2 is not performed, and the rest are the same as in the example. Here No longer.
Embodiment 3
[0052] This example provides a method for preparing a photoacoustic imaging contrast agent for cancer diagnosis. Compared with Example 1, the difference is that the RGD polypeptide in step S6 is not covalently bound, and the rest are the same as in the example. I won't repeat them here.
[0053] Such as Figure 5As shown, in terms of in vivo experiments, the good tumor targeting effect was first verified by SMMC-7721 subcutaneous tumor-bearing mice, and the comparison of tumor targeting efficiency 4 hours after injection: Example 1 Targeting group: Example 2 Targeting group: Implementation Example 3 Targeting group = 17.85%: 11.67%: 12.05%, confirming that the present invention firstly synthesizes two-dimensional Ti modified by polydopamine whose surface is rich in -OH functional groups by chemical oxidation polymerization 3 C 2 T x Nanosheets, and through electrostatic self-assembly, the hollow ZnSn(OH) surface is positively charged after amination modification 6 Microsph...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com